Kaushal Joins NMDP Board, Bringing Healthcare Technology and Investment Experience
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
NMDP, a global nonprofit leader in cell therapy, announced that Mohit Kaushal, M.D., was appointed as an incoming director, effective October 1, 2026. The appointment is part of NMDP's strategy to attract innovators to guide the organization's mission and expansion of cell therapy access. Kaushal previously served as an investor or independent board member for companies including Humedica.
From manilatimes.net
Why it matters
The appointment reflects NMDP's effort to modernize and expand access to life-saving cell therapy worldwide. Kaushal's background includes experience in healthcare technology, which is intended to guide the organization's long-term strategy.
From manilatimes.net
Who's involved
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- humedicaSpeculative
The company might see changes in investment or strategic direction related to cell therapy access.
Keep exploring
The entities involved
-
Kaushal
Indian businessperson (born 1956, child of Puran Singh)
Nothing else this week.
-
Federal Communications Commission
independent U.S. government agency
-
humedica
Nothing else this week.